Barclays Maintains Overweight on Nucor, Raises Price Target to $272

Benzinga Newsdesk www.benzinga.com Positive 72.2%

Neg 0% Neu 0% Pos 72.2%

Barclays analyst Richard Garchitorena maintains Nucor (NYSE:NUE) with a Overweight and raises the price target from $270 to $272.